FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3154903133> ?p ?o ?g. }

• W3154903133 endingPage "e524" @default.
• W3154903133 startingPage "e524" @default.
• W3154903133 abstract "Since 2018, 2 chimeric antigen receptor (CAR) T-cell therapies received approval from the European Medicine Agency, with list prices around 320 000 Euro (€) (EUR) per treatment. These high prices raise concerns for patient access and the sustainability of healthcare systems. We aimed to estimate the costs and budget impact associated with CAR T-cell therapies for current and future indications in hematological cancers from 2019 to 2029. We focused on the former France, Germany, Spain, Italy and the United Kingdom (EU-5) and the Netherlands. We conducted a review of list prices, health technology assessment reports, budget impact analysis dossiers, and published cost-effectiveness analyses. We forecasted the 10-year health expenditures on CAR T-cells for several hematological cancers in selected European Union countries. Nine cost-effectiveness studies were identified and list prices for CAR T-cell therapies ranged between 307 200 EUR and 350 000 EUR. Estimated additional costs for pre- and post-treatment were 50 359 EUR per patient, whereas the incremental costs of CAR T-cell therapy (when compared with care as usual) ranged between 276 086 EUR and 328 727 EUR. We estimated market entry of CAR T-cell therapies for chronic mantle cell lymphoma, follicular lymphoma, chronic lymphocytic leukemia, multiple myeloma, and acute myeloid leukemia in 2021, 2022, 2022, 2022, and 2025, respectively. Cumulative expenditure estimates for existing and future indications from 2019 to 2029 were on average 28.5 billion EUR, 32.8 billion EUR, and 28.9 billion EUR when considering CAR T-cell therapy costs only, CAR T-cell therapy costs including pre- and post-treatment, and incremental CAR T-cell therapy costs, respectively. CAR T-cell therapies seem to be promising treatment options for hematological cancers but the financial burden on healthcare systems in the former EU-5 and the Netherlands will contribute to a substantial rise in healthcare expenditure in the field of hematology." @default.
• W3154903133 created "2021-04-26" @default.
• W3154903133 creator A5002972322 @default.
• W3154903133 creator A5016360607 @default.
• W3154903133 creator A5022658768 @default.
• W3154903133 creator A5025894116 @default.
• W3154903133 creator A5036293139 @default.
• W3154903133 creator A5036988600 @default.
• W3154903133 creator A5038426869 @default.
• W3154903133 creator A5054017749 @default.
• W3154903133 creator A5067051752 @default.
• W3154903133 creator A5079076023 @default.
• W3154903133 date "2021-01-28" @default.
• W3154903133 modified "2023-10-16" @default.
• W3154903133 title "Health Economic Aspects of Chimeric Antigen Receptor T-cell Therapies for Hematological Cancers: Present and Future" @default.
• W3154903133 cites W1988579159 @default.
• W3154903133 cites W2008585776 @default.
• W3154903133 cites W2029468434 @default.
• W3154903133 cites W2072646319 @default.
• W3154903133 cites W2097030391 @default.
• W3154903133 cites W2106326841 @default.
• W3154903133 cites W2406954244 @default.
• W3154903133 cites W2515234975 @default.
• W3154903133 cites W2592735801 @default.
• W3154903133 cites W2604740362 @default.
• W3154903133 cites W2889863283 @default.
• W3154903133 cites W2890955229 @default.
• W3154903133 cites W2892326722 @default.
• W3154903133 cites W2893050608 @default.
• W3154903133 cites W2895644365 @default.
• W3154903133 cites W2904940919 @default.
• W3154903133 cites W2913564635 @default.
• W3154903133 cites W2917035693 @default.
• W3154903133 cites W2926160904 @default.
• W3154903133 cites W2926407393 @default.
• W3154903133 cites W2935685025 @default.
• W3154903133 cites W2945048769 @default.
• W3154903133 cites W2948047060 @default.
• W3154903133 cites W2999237747 @default.
• W3154903133 cites W3002399244 @default.
• W3154903133 cites W3015970146 @default.
• W3154903133 cites W3021761019 @default.
• W3154903133 cites W585680220 @default.
• W3154903133 doi "https://doi.org/10.1097/hs9.0000000000000524" @default.
• W3154903133 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8051992" @default.
• W3154903133 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33880433" @default.
• W3154903133 hasPublicationYear "2021" @default.
• W3154903133 type Work @default.
• W3154903133 sameAs 3154903133 @default.
• W3154903133 citedByCount "22" @default.
• W3154903133 countsByYear W31549031332021 @default.
• W3154903133 countsByYear W31549031332022 @default.
• W3154903133 countsByYear W31549031332023 @default.
• W3154903133 crossrefType "journal-article" @default.
• W3154903133 hasAuthorship W3154903133A5002972322 @default.
• W3154903133 hasAuthorship W3154903133A5016360607 @default.
• W3154903133 hasAuthorship W3154903133A5022658768 @default.
• W3154903133 hasAuthorship W3154903133A5025894116 @default.
• W3154903133 hasAuthorship W3154903133A5036293139 @default.
• W3154903133 hasAuthorship W3154903133A5036988600 @default.
• W3154903133 hasAuthorship W3154903133A5038426869 @default.
• W3154903133 hasAuthorship W3154903133A5054017749 @default.
• W3154903133 hasAuthorship W3154903133A5067051752 @default.
• W3154903133 hasAuthorship W3154903133A5079076023 @default.
• W3154903133 hasBestOaLocation W31549031331 @default.
• W3154903133 hasConcept C105639569 @default.
• W3154903133 hasConcept C121608353 @default.
• W3154903133 hasConcept C126322002 @default.
• W3154903133 hasConcept C144133560 @default.
• W3154903133 hasConcept C160735492 @default.
• W3154903133 hasConcept C17744445 @default.
• W3154903133 hasConcept C199539241 @default.
• W3154903133 hasConcept C2777525834 @default.
• W3154903133 hasConcept C2777701055 @default.
• W3154903133 hasConcept C2777938653 @default.
• W3154903133 hasConcept C2778461978 @default.
• W3154903133 hasConcept C2779338263 @default.
• W3154903133 hasConcept C2910001868 @default.
• W3154903133 hasConcept C3875195 @default.
• W3154903133 hasConcept C71924100 @default.
• W3154903133 hasConceptScore W3154903133C105639569 @default.
• W3154903133 hasConceptScore W3154903133C121608353 @default.
• W3154903133 hasConceptScore W3154903133C126322002 @default.
• W3154903133 hasConceptScore W3154903133C144133560 @default.
• W3154903133 hasConceptScore W3154903133C160735492 @default.
• W3154903133 hasConceptScore W3154903133C17744445 @default.
• W3154903133 hasConceptScore W3154903133C199539241 @default.
• W3154903133 hasConceptScore W3154903133C2777525834 @default.
• W3154903133 hasConceptScore W3154903133C2777701055 @default.
• W3154903133 hasConceptScore W3154903133C2777938653 @default.
• W3154903133 hasConceptScore W3154903133C2778461978 @default.
• W3154903133 hasConceptScore W3154903133C2779338263 @default.
• W3154903133 hasConceptScore W3154903133C2910001868 @default.
• W3154903133 hasConceptScore W3154903133C3875195 @default.
• W3154903133 hasConceptScore W3154903133C71924100 @default.
• W3154903133 hasIssue "2" @default.
• W3154903133 hasLocation W31549031331 @default.
• W3154903133 hasLocation W31549031332 @default.

• next